.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,247,395

« Back to Dashboard

Claims for Patent: 8,247,395

Title:Topical skin care composition
Abstract: A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.
Inventor(s): Puglia; Nancy (Sanford, FL), Roth; Jerry (Sanford, FL), Ramirez; Rosario (Sanford, FL)
Assignee: Galderma S.A. (Cham, CH)
Application Number:13/074,744
Patent Claims: 1. A medicated composition for topical application comprising active ingredients consisting of fluocinolone acetonide, hydroquinone and tretinoin, the composition being an emulsion obtainable by a process comprising the steps of: (a) preparing an aqueous composition comprising water and at least one hydrophilic compound while heating at a temperature in the range of about 75.degree. C. to about 80.degree. C.; (b) preparing a non-aqueous composition comprising at least two hydrophobic compounds while heating at a temperature in the range of about 75.degree. C. to about 80.degree. C.; (c) combining the aqueous and non-aqueous compositions to form a mixture, wherein steps (a) through (c) are conducted in the absence of an emulsifier; (d) adding at least one emulsifier to the mixture comprising the aqueous and non-aqueous compositions; (e) adding tretinoin to the mixture comprising the aqueous and non-aqueous compositions; (f) adding fluocinolone acetonide to the mixture comprising the aqueous and non-aqueous compositions; (g) adding hydroquinone to the mixture comprising the aqueous and non-aqueous compositions, wherein the hydroquinone is added after adding the at least one emulsifier; and (h) homogenizing the mixture to form the emulsion.

2. The medicated composition of claim 1, wherein the aqueous composition comprises butylated hydroxytoluene.

3. The medicated composition of claim 1, wherein the aqueous composition comprises butylated hydroxytoluene and magnesium aluminum silicate.

4. The medicated composition of claim 1, wherein the non-aqueous composition comprises at least two hydrophobic compounds selected from the group consisting of cetyl alcohol, stearic acid, stearyl alcohol, methyl gluceth, methylparaben, propylparaben, and glycerin.

5. The medicated composition of claim 1, wherein the non-aqueous composition consists essentially of cetyl alcohol, stearic acid, stearyl alcohol, methyl gluceth, methylparaben, propylparaben, and glycerin.

6. The medicated composition of claim 1, wherein step (c) further comprises cooling the mixture to a temperature in the range of about 68.degree. C. to about 72.degree. C.

7. The medicated composition of claim 1, wherein the at least one emulsifier is a combination of glycerol stearate and polyethylene glycol stearate.

8. The medicated composition of claim 1, further comprising cooling the mixture after adding at least one emulsifier.

9. The medicated composition of claim 8, further comprising adding citric acid to the mixture after cooling.

10. The medicated composition of claim 9, further comprising cooling the mixture after adding citric acid.

11. The medicated composition of claim 1, wherein step (e) is conducted during step (d).

12. The medicated composition of claim 11, further comprising cooling the mixture after adding at least one emulsifier and tretinoin.

13. The medicated composition of claim 12, further comprising adding citric acid to the mixture after cooling.

14. The medicated composition of claim 13, further comprising cooling the mixture after adding citric acid.

15. The medicated composition of claim 1, wherein steps (e) and (f) are conducted during step (d).

16. The medicated composition of claim 15, further comprising cooling the mixture after adding at least one emulsifier, tretinoin and fluocinolone acetonide.

17. The medicated composition of claim 16, further comprising adding citric acid to the mixture after cooling.

18. The medicated composition of claim 17, further comprising cooling the mixture after adding citric acid.

19. The medicated composition of claim 1, further comprising cooling the mixture before adding the hydroquinone.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc